J9177
HCPCSInj enfort vedo-ejfv 0.25mg
Official HCPCS Level II long descriptor
Injection, enfortumab vedotin-ejfv, 0.25 mg
HCPCS Level II code J9177 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Inj enfort vedo-ejfv 0.25mg
Added to HCPCS: 2020-07-01
Nearby codes in J9
- J9155Degarelix injection
- J9161Inj denileuk difti-cxdl 1mcg
- J9171Docetaxel injection
- J9172Docetaxel (docivyx), 1 mg
- J9173Inj., durvalumab, 10 mg
- J9174Inj, docetaxel (beizray) 1mg
- J9175Elliotts b solution per ml
- J9176Injection, elotuzumab, 1mg
- J9178Inj, epirubicin hcl, 2 mg
- J9179Eribulin mesylate injection
- J9181Etoposide injection
- J9183Gemcitabine intravesical sys
- J9184Inj gemcitabin (avyxa) 200mg
- J9185Fludarabine phosphate inj
- J9190Fluorouracil injection
- J9196Inj gemcitabine hcl (accord)
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.